When purchasing AOD-9604 5mg research vials, UK laboratories need more than a compound name and an advertised purity percentage. A complete product specification should identify the peptide, explain the stated quantity and provide information that can be matched to the supplied batch.
These details help researchers assess whether a vial meets their analytical requirements before ordering.
Essential AOD-9604 5mg Vial Specifications
A supplier should make the following information available.
| Specification | What to verify |
|---|---|
| Compound identity | AOD-9604 designation and peptide identifiers |
| Strength | Stated 5mg quantity and its basis |
| Format | Lyophilised powder or prepared solution |
| Composition | Relevant excipients, solvents or counterions |
| Batch number | Unique lot identifier |
| COA | Analytical report applicable to the supplied batch |
| Packaging | Container type, closure and labelling |
| Storage | Conditions supported by product information |
A missing specification does not necessarily mean the material is unsuitable, but laboratories should request clarification before approving procurement.
Does a 5mg Label Confirm Peptide Content?
No. A vial labelled 5mg carries a quantity claim, not independent proof of actual peptide content.
For lyophilised material, laboratories should establish whether the stated quantity refers to peptide content or total formulated material.
For liquid preparations, the supplier should also specify the solution volume and concentration.
A chromatographic purity percentage cannot substitute for a suitable quantitative content assay.
What Should the AOD-9604 COA Confirm?
A certificate of analysis should identify the relevant compound and batch.
HPLC may provide information about chromatographic purity, while mass spectrometry can support molecular identity assessment.
Neither method alone establishes every quality attribute.
Laboratories should also check whether the vial label, product listing and COA contain consistent identifiers.
Packaging and Storage Requirements
Research vials should have legible labels and appropriate container closures.
Powder and liquid formats may require different storage conditions. Suppliers should provide relevant handling information rather than assuming that every AOD-9604 formulation has identical stability.
For format differences, see our AOD-9604 powder vs liquid guide.
Buyers can also review Peptide Lab Direct UK’s research catalogue when comparing available specifications.
Frequently Asked Questions
1. What does AOD-9604 5mg mean?
It indicates a stated quantity of 5mg per product unit, subject to the supplier’s defined content basis.
2. Should every vial have a batch number?
Laboratories should require traceable identification linking the material to its supporting records.
3. Does 99% purity prove 5mg content?
No. Purity and quantitative content are different measurements.
4. Can AOD-9604 be supplied as a solution?
Prepared research solutions may be offered; their volume, concentration and composition should be specified.
5. Should storage information appear on the listing?
Relevant storage information should be accessible before purchasing.
6. Is a COA sufficient on its own?
Not always. Its methods, scope and relationship to the supplied batch must be assessed.
Conclusion
AOD-9604 5mg research vials should be evaluated through clear specifications, batch traceability and appropriate analytical documentation. A complete product description helps UK laboratories compare materials without relying on unsupported claims.
For laboratory research only. Not intended for human administration.
Scientific References
- ICH Q2(R2), Validation of Analytical Procedures: https://www.ich.org/page/quality-guidelines
- ISO/IEC 17025:2017, Testing and Calibration Laboratory Competence: https://www.iso.org/standard/66912.html
3 comments